European Journal of Cancer
Volume 46, Issue 1 , Pages 72-83, January 2010

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas:

An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

Presented in part at the 44th Annual Meeting of the American Society of Clinical Oncology, May 30–June 3, 2008, Chicago, Illinois.

  • Stefan Sleijfer

      Affiliations

    • Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Address: Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel.: +31 (0)10 7041733; fax: +31 (0)10 7041003.
    • ,
  • Monia Ouali

      Affiliations

    • EORTC Data Center, Brussels, Belgium
    • ,
  • Martine van Glabbeke

      Affiliations

    • EORTC Data Center, Brussels, Belgium
    • ,
  • Anders Krarup-Hansen

      Affiliations

    • Department of Oncology, University Hospital Herlev, Copenhagen, Denmark
    • ,
  • Sjoerd Rodenhuis

      Affiliations

    • Department of Medical Oncology, National Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Axel Le Cesne

      Affiliations

    • Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France
    • ,
  • Pancras C.W. Hogendoorn

      Affiliations

    • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Jaap Verweij

      Affiliations

    • Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Jean-Yves Blay

      Affiliations

    • Department of Medical Oncology, Centre Leon Berard, Lyon, France

Received 29 July 2009; received in revised form 13 September 2009; accepted 17 September 2009. published online 23 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00719-9

doi:10.1016/j.ejca.2009.09.022

European Journal of Cancer
Volume 46, Issue 1 , Pages 72-83, January 2010

Article Tools

* Image Usage & Resolution